PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Diabetes & Metabolism Journal10.4093/dmj.2019.01302019434545Letter: Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes Metab J 2019;43;276-86)Hannah Seok, Tae Seo Sohnhttps://synapse.koreamed.org/pdf/10.4093/dmj.2019.0130, https://synapse.koreamed.org/DOIx.php?id=10.4093/dmj.2019.0130, https://e-dmj.org/DOIx.php?id=10.4093/dmj.2019.0130
Diabetes & Metabolism Journal10.4093/dmj.2019.01482019434547Response: Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes metab J 2019;43;276-86)Tae Jung Oh, Sung Hee Choihttps://synapse.koreamed.org/pdf/10.4093/dmj.2019.0148, https://synapse.koreamed.org/DOIx.php?id=10.4093/dmj.2019.0148, https://e-dmj.org/DOIx.php?id=10.4093/dmj.2019.0148
Diabetes, Obesity and Metabolism10.1111/dom.122342013165443-450A randomized controlled trial of the efficacy and safety of saxagliptin as add-on therapy in patients with type 2 diabetes and inadequate glycaemic control on metformin plus a sulphonylureaR. G. Moses, S. Kalra, D. Brook, J. Sockler, J. Monyak, J. Visvanathan, M. Montanaro, S. A. Fisherhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fdom.12234, http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12234/fullpdf
Diabetes & Metabolism Journal10.4093/dmj.2018.00512019433276Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled TrialTae Jung Oh, Jae Myung Yu, Kyung Wan Min, Hyun Shik Son, Moon Kyu Lee, Kun Ho Yoon, Young Duk Song, Joong Yeol Park, In Kyung Jeong, Bong Soo Cha, Yong Seong Kim, Sei Hyun Baik, In Joo Kim, Doo Man Kim, Sung Rae Kim, Kwan Woo Lee, Jeong Hyung Park, In Kyu Lee, Tae Sun Park, Sung Hee Choi, Sung Woo Parkhttps://synapse.koreamed.org/pdf/10.4093/dmj.2018.0051, https://synapse.koreamed.org/DOIx.php?id=10.4093/dmj.2018.0051, https://e-dmj.org/DOIx.php?id=10.4093/dmj.2018.0051
Diabetes, Obesity and Metabolism10.1111/j.1463-1326.2012.01620.x20121410927-936Efficacy and safety of alogliptin added to metformin in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial with an open-label, long-term extension studyY. Seino, Y. Miyata, S. Hiroi, M. Hirayama, K. Kakuhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1463-1326.2012.01620.x, http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1463-1326.2012.01620.x/fullpdf
Diabetes Therapy10.1007/s13300-015-0099-x20156117-27Efficacy and Safety of a Single-Pill Combination of Vildagliptin and Metformin in Japanese Patients with Type 2 Diabetes Mellitus: A Randomized, Double-Blind, Placebo-Controlled TrialMasato Odawara, Mika Yoshiki, Misako Sano, Izumi Hamada, Valentina Lukashevich, Wolfgang Kothnyhttp://link.springer.com/content/pdf/10.1007/s13300-015-0099-x.pdf, http://link.springer.com/article/10.1007/s13300-015-0099-x/fulltext.html, http://link.springer.com/content/pdf/10.1007/s13300-015-0099-x, http://link.springer.com/content/pdf/10.1007/s13300-015-0099-x.pdf
Diabetes/Metabolism Research and Reviews10.1002/dmrr.13062012283268-275Efficacy and safety of saxagliptin in drug-naïve Asian patients with type 2 diabetes mellitus: a randomized controlled trialChang Yu Pan, Wenying Yang, Conrad Tou, Ingrid Gause-Nilsson, June Zhaohttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fdmrr.1306, http://onlinelibrary.wiley.com/wol1/doi/10.1002/dmrr.1306/fullpdf
Diabetes Research and Clinical Practice10.1016/j.diabres.2011.07.0352011942217-224Efficacy and safety of saxagliptin added to metformin in Asian people with type 2 diabetes mellitus: A randomized controlled trialWenying Yang, Chang Yu Pan, Conrad Tou, June Zhao, Ingrid Gause-Nilssonhttps://api.elsevier.com/content/article/PII:S0168822711004116?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0168822711004116?httpAccept=text/plain
Diabetes, Obesity and Metabolism10.1111/dom.122292013165403-409Efficacy and safety of vildagliptin in patients with type 2 diabetes mellitus inadequately controlled with dual combination of metformin and sulphonylureaV. Lukashevich, S. Del Prato, M. Araga, W. Kothnyhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fdom.12229, https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.12229, https://onlinelibrary.wiley.com/doi/full-xml/10.1111/dom.12229, http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12229/fullpdf
Diabetes, Obesity and Metabolism10.1111/dom.124692015177699-702Efficacy and safety of empagliflozin twice daily versus once daily in patients with type 2 diabetes inadequately controlled on metformin: a 16-week, randomized, placebo-controlled trialS. Ross, C. Thamer, J. Cescutti, T. Meinicke, H. J. Woerle, U. C. Broedlhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fdom.12469, http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12469/fullpdf